Steroid treatment and aseptic necrosis of the femoral head in renal transplant recipients
- PMID: 6385405
Steroid treatment and aseptic necrosis of the femoral head in renal transplant recipients
Abstract
The subject of our study was 546 renal transplant recipients with a graft survival for minimum 12 months. Of these, 29 renal recipients (5.3%) developed aseptic necrosis of the femoral head. The examination revealed that there were no significant differences between the renal recipients with hip necrosis and the control group in the total quantities of administered glucocorticosteroids, whereas there was a highly significant correlation between the two groups in the number of the intravenously administered methylprednisolone pulse doses.
Similar articles
-
Osteonecrosis of the hip in renal transplant recipients. Changes in functional status and magnetic resonance imaging findings over three years in three hundred five patients.Rev Rhum Engl Ed. 1996 Jun;63(6):413-20. Rev Rhum Engl Ed. 1996. PMID: 8817751
-
Aseptic necrosis of bone following renal transplantation: relation with hyperparathyroidism.Nephrol Dial Transplant. 1989;4(2):123-8. Nephrol Dial Transplant. 1989. PMID: 2540458
-
Degree of corticosteroid treatment within the first 2 months of renal transplantation has a strong influence on the incidence of osteonecrosis of the femoral head.Acta Orthop. 2008 Oct;79(5):631-6. doi: 10.1080/17453670810016641. Acta Orthop. 2008. PMID: 18839369
-
Glucocorticodids and renal transplant osteonecrosis.Adv Exp Med Biol. 1984;171:353-9. Adv Exp Med Biol. 1984. PMID: 6372398 Review. No abstract available.
-
Steroid arthropathy of the hip.Clin Orthop Relat Res. 1973 Jan-Feb;(90):50-6. Clin Orthop Relat Res. 1973. PMID: 4571764 Review. No abstract available.
Cited by
-
High-Dose Corticosteroid Use and Risk of Hip Osteonecrosis: Meta-Analysis and Systematic Literature Review.J Arthroplasty. 2015 Sep;30(9):1506-1512.e5. doi: 10.1016/j.arth.2015.03.036. Epub 2015 Apr 8. J Arthroplasty. 2015. PMID: 25900167 Free PMC article.
-
Corticosteroid-induced adverse events in adults: frequency, screening and prevention.Drug Saf. 2007;30(10):861-81. doi: 10.2165/00002018-200730100-00005. Drug Saf. 2007. PMID: 17867724 Review.
-
Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia.Blood. 2011 Feb 24;117(8):2340-7; quiz 2556. doi: 10.1182/blood-2010-10-311969. Epub 2010 Dec 10. Blood. 2011. PMID: 21148812 Free PMC article. Clinical Trial.
-
Survey of the long term incidence of osteonecrosis of the hip and adverse medical events in rheumatoid arthritis after high dose intravenous methylprednisolone.Ann Rheum Dis. 1988 Nov;47(11):930-3. doi: 10.1136/ard.47.11.930. Ann Rheum Dis. 1988. PMID: 3207375 Free PMC article. Clinical Trial.
-
Steroid induced osteonecrosis: An analysis of steroid dosing risk.Autoimmun Rev. 2010 Sep;9(11):721-43. doi: 10.1016/j.autrev.2010.06.007. Epub 2010 Jul 9. Autoimmun Rev. 2010. PMID: 20621176 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical